CD49d promotes disease progression in chronic lymphocytic leukemia, page-7

@Shyam 1996
Hi
yes i know DMD is our priority, this is not my point, i have been in ANP long term and have always maintained they have always kicked the goals pipeline wise and the only reason i am still around i believe in the pipeline, but IMHO they have never put any emphasis on ROI for its investors,

There is more to running the company than pipeline focus, it is a two headed coin they have shareholders as well, if a partnership does not come to fruition, Raising will not be a problem AT WHAT COST

i will be left asking why has this not been promoted more to high net worth investors over our milestones achieved throughout the year

The above is a classic example of missed opportunity to promote what i see as major news and price sensitive information

WHY

Look at the promotion for all we have achieved over this last twelve months it borders on a joke

Will catch up further on this subject later